Adverum Biotechnologies
ADVM
ADVM
59 hedge funds and large institutions have $97.9M invested in Adverum Biotechnologies in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 8 closing their positions.
Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
0.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
15
Reduced
20
Closed
8
Calls
$420K
Puts
–
Net Calls
+$420K
Net Calls Change
+$295K
Top Buyers
| 1 |
VA
1
VR Adviser
New York
|
$9.86M |
| 2 |
2
Citigroup
New York
|
$715K |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$356K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$6.28M |
| 5 |
5
Renaissance Technologies
New York
|
$2M |
